Ensign Peak Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Hold
844
﹤0.01% 1068
2026
Q1
$319K Sell
844
-401
-32% -$172K ﹤0.01% 1101
2025
Q4
$533K Sell
1,245
-2,074
-62% -$903K ﹤0.01% 946
2025
Q3
$1.49M Sell
3,319
-875
-21% -$396K ﹤0.01% 889
2025
Q2
$2.04M Sell
4,194
-1,629
-28% -$928K ﹤0.01% 902
2025
Q1
$3.58M Sell
5,823
-665
-10% -$378K 0.01% 714
2024
Q4
$3.44M Sell
6,488
-3,811
-37% -$2.15M 0.01% 754
2024
Q3
$6.19M Buy
10,299
+1,540
+18% +$873K 0.01% 565
2024
Q2
$4.75M Buy
8,759
+390
+5% +$223K 0.01% 634
2024
Q1
$5.37M Sell
8,369
-897
-10% -$545K 0.01% 619
2023
Q4
$5.42M Buy
9,266
+202
+2% +$113K 0.01% 609
2023
Q3
$4.71M Buy
9,064
+3,188
+54% +$1.66M 0.01% 583
2023
Q2
$3.18M Buy
5,876
+1,600
+37% +$875K 0.01% 718
2023
Q1
$2.3M Buy
4,276
+450
+12% +$229K 0.01% 792
2022
Q4
$1.95M Sell
3,826
-1,650
-30% -$803K ﹤0.01% 824
2022
Q3
$2.39M Sell
5,476
-720
-12% -$346K 0.01% 721
2022
Q2
$2.91M Hold
6,196
0.01% 682
2022
Q1
$3.14M Hold
6,196
0.01% 718
2021
Q4
$3.28M Sell
6,196
-7,740
-56% -$3.72M 0.01% 794
2021
Q3
$6.48M Sell
13,936
-720
-5% -$339K 0.01% 552
2021
Q2
$6.96M Sell
14,656
-1,195
-8% -$574K 0.01% 533
2021
Q1
$7.29M Buy
15,851
+908
+6% +$445K 0.02% 501
2020
Q4
$7.96M Sell
14,943
-1,413
-9% -$694K 0.02% 474
2020
Q3
$7.86M Buy
16,356
+1,600
+11% +$785K 0.02% 494
2020
Q2
$6.66M Buy
14,756
+1,420
+11% +$634K 0.02% 526
2020
Q1
$5.78M Sell
13,336
-10,220
-43% -$4.56M 0.02% 474
2019
Q4
$10.3M Buy
+23,556
New +$9.91M 0.03% 433

Other funds holding CHE

Ensign Peak Advisors's CHE Position: Q2 2026 in Review

Ensign Peak Advisors held its Chemed (CHE) position steady in Q2 2026 at 844 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Ensign Peak Advisors first reported a position in CHE in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.3M in Q4 2019. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Ensign Peak Advisors held 844 shares of Chemed worth $393K as of Q2 2026.
  • Ensign Peak Advisors left its Chemed share count unchanged in Q2 2026.
  • Chemed made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1068 holding.
  • Ensign Peak Advisors first reported a position in Chemed in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Chemed position peaked at $10.3M in Q4 2019.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.